Haematopoietic progenitor cells from the common marmoset as targets of gene transduction by retroviral and adenoviral vectors

European Journal of Haematology

Volumn 66, Issue 4, 2001, Pages 272-280

  Hibino, Hitoshi ^a   Tani, Kenzaburo ^a,c   Sugiyama, Hajime ^a   Suzuki, Shuzo ^b   Wu, Ming Shiuan ^a   Izawa, Kiyoko ^a   Hase, Hidenori ^a   Nakazaki, Yukoh ^a   Tanabe, Tsuyoshi ^a   Ooi, Jun ^a   Izeki, Toru ^a   Tojo, Arinobu ^a   Saitoh, Izumu ^a   Tanioka, Yoshikuni ^b   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c NONE   (Japan)

Author keywords

Gene therapy; Haematopoietic progenitor cells; Lymphocytes; Non human primate

Indexed keywords

BETA GALACTOSIDASE; CD14 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; MONOCLONAL ANTIBODY; STEM CELL FACTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CROSS REACTION; FLOW CYTOMETRY; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; LYMPHOCYTE PROLIFERATION; MARMOSET; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; STROMA CELL;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW CELLS; CALLITHRIX; CROSS REACTIONS; FEMALE; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LAC OPERON; LYMPHOCYTES; MALE; MODELS, ANIMAL; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0035002549     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.066004272.x     Document Type: Article

References (28)

1. 1. ROBBINS PB, SKELTON DC, YU X-J, HALENE S, LEONARD EH, KOHN DB. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc Natl Acad Sci USA 1998;95:10182-10187.
2. 2. ALLAY JA, PERSONS DA, GALIPEAU J, et al. In vivo selection of retrovirally transduced hematopoietic stem cells. Nature Med 1998;4:1136-1143.
3. 3. DAI Y, SCHWARZ EM, GU D, ZHANG W-W, SARVETNICK N, VERMA IM. Cellular and humoral immuno responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995;92:1401-1405.
4. 4. APPLEBAUM-BOWDEN D, KOBAYASHI J, KASHYAP VS, et al. Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium. J Clin Invest 1996;97:799-805.
5. 5. DONAHUE RE, KESSLER SW, BODINE D, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992;176:1125-1135.
6. 6. NEUBERT R, JACOB-MULLER U, STAHLMANN R, HELGE H, NEUBERT D. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. I. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch Toxicol 1990;64:345-359.
7. 7. KLUG S, NEUBERT R, STAHLMANN R, et al. Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). I. General toxicity and hematological changes. Arch Toxicol 1994;68:619-631.
8. 8. MICHALEVCZ R, HETHERINGTON CM, HANN I, BLACKLOCK HA. Studies of sub-human primate (marmoset) pluripotent hemopoietic stem cells (CFU-GEMM) in vitro. J Med Primatol 1985;14:245-253.
9. 9. SCHOOLEY RT, BYINGTON R, FALK Jr, LA. Phenotypic analysis of New World primate mononuclear cell surface antigens. J Med Primatol 1983;12:30-40.
10. 10. NEUBERT R, FOERSTER M, NOGUERIRA AC, HELGE H. Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset. Life Science 1996;58:317-324.
11. 11. HIBINO H, TANI K, IKEBUCHI K, et al. Common marmoset as a target preclinical primate for cytokine and gene therapy studies. Blood 1999;93:2839-2848.
12. 12. DANOS O, MULLIGAN RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1998;85:6460-6464.
13. 13. MIYAKE S, MAKIMURA M, KANAGAE Y, et al. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 1996;93:1320-1324.
14. 14. VAN GILS FCJM, BUDEL LM, BURGER H, VAN LEEN RW, LOWENBERG B, WAGEMAKER G. Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF. Exp Hematol 1994;22:248-255.
15. 15. CARTER DL, SHIEH TM, BLOSSER RL, et al. CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry 1999;37:41-50.
16. 16. KRAUSE DS, FACKLER MJ, CIVIN CI, MAY WS. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
17. 17. LAVER JH, ABBOUD MR, KAWASHIMA I, LEARY AG, ASHMAN LK, OGAWA M. Characterization of c-kit expression by primitive hematopoietic progenitors in umbilical cord blood. Exp Hematol 1995;23:1515-1519.
18. 18. HESDORFFER C, AYELLO J, WARD M, et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as bone marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol 1998;16:165-172.
19. 19. HANANIA EG, GILES RE, KAVANAGH J, et al. Results of MDR-1 vector modification trial indicate that granulocyte/ macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci USA 1996;93:15346-15351.
20. 20. BROWN J, GREAVES MF, MOLGAARD HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in hematopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 1991;3:175-184.
21. 21. HE XY, ANTAO V, BASILA ML, DAVIS B. Isolation and molecular characterization of the human CD34 gene. Blood 1992;79:2296-2302.
22. 22. MCSWEENEY PA, ROULEAU KA, STORB R, et al. Canine CD34: Cloning of the cDNA and evaluation of an antiserum to recombinant protein. Blood 1996;83:1992-2003.
23. 23. YARDEN Y, KUANG W-J, YANG-FENG T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-3351.
24. 24. QIU F, RAY P, BROWN K, et al. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family -oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 1998;7:1003-1011.
25. 25. WATANABE T, KUSZYNSKI C, INO K, et al. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 1996;87:5032-5039.
26. 26. NEERING SJ, HARDY SF, MINAMOTO D, SPRATT SK, JORDAN CT. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996;88:1147-1155.
27. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999;283:682-686.
28. - human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999;96:2988-2993.